India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...

A new tooth-regrowing drug has finally entered human trials after months of waiting and promising clinical trials on mice and ...

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...

Novo Nordisk shareholders were seeking on Friday to find out why such a high number of patients in the late-stage trial of ...

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

Investors and analysts had eagerly awaited this data as a test of Novo’s case that it has a strong pipeline of drugs to ...

Novo shares lost nearly a fifth of their value after an experimental combination treatment called cagrisema fell short of the ...

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

New research has found that an existing ADHD medication greatly reduced the number of days people with a methamphetamine ...

Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...

Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...

A former Montana Tech associate athletic director arrested back in March on suspicion of multiple felony drug charges is now ...